Morgan L. Maeder, et al. Therapeutic Correction of an LCA-Causing Splice Defect in the CEP290 Gene by CRISPR/Cas-Mediated Genome Editing. Presented at the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016 in Seattle, WA.

Feb

25

Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update

Feb

18

Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update

Feb

8

Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer